CH Biotech R&D Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 840.680 million compared to TWD 879.780 million a year ago. Operating income was TWD 257.833 million compared to TWD 368.465 million a year ago. Net income was TWD 190.465 million compared to TWD 285.422 million a year ago. Basic earnings per share was TWD 2.37 compared to TWD 3.56 a year ago. Diluted earnings per share was TWD 2.34 compared to TWD 3.52 a year ago.